• Cervical cancer: no survival benefit for ACT after concurrent chemoradiation

    Findings from ACTLACC trial.

  • Cervical cancer: chemoradiation with doublet tops monotherapy in meta-analysis

    Platinum-based doublet therapy was less tolerable.

  • Cervical cancer: HDR brachytherapy effective with less toxicity

    Similar local disease control, cancer-specific survival vs LDR brachytherapy.

  • The impact of the HSCA on cervical cancer screening rates

    Exploring the impacts of the 2012 Health and Social Care Act reforms on clinical activity in the English NHS.

  • Northern Ireland's health department makes two major health protection declarations
    Northern Ireland's health department makes two major health protection declarations

    Announcements pertaining to HPV vaccination and bowel screening.

  • Cervical cancer: cetuximab fails phase 2 in advanced/recurrent disease

    PIK3CA mutation status predicted resistance to cetuximab.

  • Therapeutic vaccine targets HPV, clears cervical cancer precursors

    Phase 2 trial shows efficacy regardless of high-risk HPV type.

  • Cervical cancer: the study behind FDA approval of pembrolizumab

    Data from the phase 2 pembrolizumab KEYNOTE-158 basket study.

  • AACR 2019—​​​​​​​HPV vaccination rates low in adults at high risk for HIV

    HIV coinfection increases HPV-related cancer risk.

  • PHE launches new cervical screening campaign
    PHE launches new cervical screening campaign

    The campaign aims to improve uptake by encouraging women to attend screening.

  • FDA sounds warning on robot-assisted mastectomy, other surgeries

    Safety, efficacy not established; some evidence points to lower long-term survival.

  • Cervical cancer: scaled-up HPV vaccine, screening could prevent 13 million cases by 2069

    Rapid worldwide scale-up could virtually eliminate the disease by century's end.

  • Male circumcision reduces women's risk for cervical cancer, STIs

    Findings affirm public health benefits.

  • Routine primary high-risk HPV testing in England
    Routine primary high-risk HPV testing in England

    Findings from the pilot project strongly support an extension of screening intervals.

  • Artificial intelligence outperforms experts in identifying cervical precancer
    Artificial intelligence outperforms experts in identifying cervical precancer

    Experts say a new algorithm could revolutionise cervical cancer screening.

  • SLE linked to higher risk for 15 cancers in meta-analysis

    Overall cancer risk boosted by 28%.

  • HIV-infected women underscreened for HPV

    Testing intervals often longer than recommended.

  • Load more